LibiGel Approval Status
- FDA approved: No
- Brand name: LibiGel
- Generic name: testosterone
- Dosage form: Gel
- Company: Antares Pharma, Inc. and BioSante Pharmaceuticals Inc.
- Treatment for: Hypoactive Sexual Desire Disorder
LibiGel (testosterone) is a transdermal gel formulation of testosterone in development for the treatment of hypoactive sexual desire disorder.
Development Status and FDA Approval Process for LibiGel
|Jun 21, 2010||BioSante Pharmaceuticals Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel|
|Oct 2, 2007||Antares Reports Product Progress in Growing Women's Health Portfolio|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.